{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:54:46Z","timestamp":1790643286328,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,16]],"date-time":"2017-07-16T00:00:00Z","timestamp":1500163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,16]],"date-time":"2017-07-16T00:00:00Z","timestamp":1500163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK094176"],"award-info":[{"award-number":["U01 DK094176"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00125-017-4374-4","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T23:10:15Z","timestamp":1500160215000},"page":"2084-2091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT\/EDIC study"],"prefix":"10.1007","volume":"60","author":[{"name":"the DCCT\/EDIC Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Bebu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara H.","family":"Braffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Lachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,16]]},"reference":[{"key":"4374_CR1","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.2337\/dc06-1161","volume":"29","author":"TJ Orchard","year":"2006","unstructured":"Orchard TJ, Costacou T, Kretowski A, Nesto RW (2006) Type 1 diabetes and coronary artery disease. Diabetes Care 29:2528\u20132538","journal-title":"Diabetes Care"},{"key":"4374_CR2","doi-asserted-by":"publisher","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","volume":"9","author":"SJ Livingstone","year":"2012","unstructured":"Livingstone SJ, Looker HC, Hothersall EJ et al (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 9:e1001321","journal-title":"PLoS Med"},{"key":"4374_CR3","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643\u20132653","journal-title":"N Engl J Med"},{"key":"4374_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care 39:686\u2013693","journal-title":"Diabetes Care"},{"key":"4374_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/db15-1517","volume":"65","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group (2016) Risk factors for cardiovascular disease in type 1 diabetes. Diabetes 65:1370\u20131379","journal-title":"Diabetes"},{"key":"4374_CR6","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2337\/dc06-1441","volume":"30","author":"AD Paterson","year":"2007","unstructured":"Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS (2007) Diabetes control and complications trial\/epidemiology of diabetes interventions and complications research group: the effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 30:2107\u20132112","journal-title":"Diabetes Care"},{"key":"4374_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","volume":"171","author":"IH de Boer","year":"2011","unstructured":"de Boer IH, Rue TC, Cleary PA et al (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort. Arch Intern Med 171:412\u2013420","journal-title":"Arch Intern Med"},{"key":"4374_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2337\/diacare.22.1.99","volume":"22","author":"The DCCT\/EDIC Research Group","year":"1999","unstructured":"The DCCT\/EDIC Research Group (1999) Epidemiology of diabetes interventions and complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort. Diabetes Care 22:99\u2013111","journal-title":"Diabetes Care"},{"key":"4374_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2337\/diab.35.5.530","volume":"35","author":"The DCCT Research Group","year":"1986","unstructured":"The DCCT Research Group (1986) The diabetes control and complications trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 35:530\u2013545","journal-title":"Diabetes"},{"key":"4374_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"4374_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2337\/dc13-2116","volume":"37","author":"JM Lachin","year":"2014","unstructured":"Lachin JM, Orchard TJ, Nathan DM (2014) DCCT\/EDIC research group: update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 37:39\u201343","journal-title":"Diabetes Care"},{"key":"4374_CR12","volume-title":"Dynamic regression models for survival data","author":"T Martinussen","year":"2006","unstructured":"Martinussen T, Scheike TH (2006) Dynamic regression models for survival data. Springer, New York"},{"key":"4374_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RBS D'Agostino","year":"2008","unstructured":"D'Agostino RBS, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation 117:743\u2013753","journal-title":"Circulation"},{"key":"4374_CR14","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G et al (2014) American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American heart association task force on practice guidelines. J Am Coll Cardiol 63:2935\u20132959","journal-title":"J Am Coll Cardiol"},{"key":"4374_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92\u2013105","journal-title":"Biometrics"},{"key":"4374_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/EDE.0b013e31821c680c","volume":"22","author":"T Lange","year":"2011","unstructured":"Lange T, Hansen JV (2011) Direct and indirect effects in a survival context. Epidemiology 22:575\u2013581","journal-title":"Epidemiology"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4374-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4374-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4374-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:33:01Z","timestamp":1589563981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4374-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,16]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["4374"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4374-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,16]]},"assertion":[{"value":"2 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All DCCT\/EDIC data files are available at the NIDDK Repository ().","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The DCCT\/EDIC has been supported by cooperative agreement grants (1982\u20131993, 2012\u20132017) and contracts (1982\u20132012) with the Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (current grant numbers U01 DK094176 and U01 DK094157), and through support by the National Eye Institute, the National Institute of Neurologic Disorders and Stroke, the General Clinical Research Centers Program (1993\u20132007) and Clinical Translational Science Center Program (2006-present), Bethesda, MD, USA. The following industry contributors had no role in the DCCT\/EDIC study but have provided free or discounted supplies or equipment to support participants\u2019 adherence to the study: Abbott Diabetes Care (Alameda, CA, USA), Animas (Westchester, PA, USA), Bayer Diabetes Care (North America Headquarters, Tarrytown, NY, USA), Becton Dickinson (Franklin Lakes, NJ, USA), Eli Lilly (Indianapolis, IN, USA), Extend Nutrition (St Louis, MO, USA), Insulet Corporation (Bedford, MA, USA), Lifescan (Milpitas, CA, USA), Medtronic Diabetes (Minneapolis, MN, USA), Nipro Home Diagnostics (Ft Lauderdale, FL, USA), Nova Diabetes Care (Billerica, MA, USA), Omron (Shelton, CT, USA), Perrigo Diabetes Care (Allegan, MI, USA), Roche Diabetes Care (Indianapolis, IN, USA), and Sanofi-Aventis (Bridgewater, NJ, USA). The study sponsor was not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"IB and JML wrote the initial draft of the manuscript. IB and BHB conducted statistical analyses. All authors contributed to the study design and the interpretation of the data, revised the manuscript for important intellectual content and approved the final version. IB is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}